Clinical Trials Browser

fezolinetant × Breast × Clear all

NCT06917313 2026-06-02

FLASH-Breast: Evaluating the Efficacy of Fezolinetant in Reducing Vasomotor Symptoms in Women With Breast Cancer on Endocrine Therapy

Phase 2 Recruiting

Breast Cancer Early Stage Breast Cancer (Stage 1-3)

NCT06617455 2026-05-06

VEnT

Phase 2 Terminated

Carcinoma, Intraductal, Noninfiltrating